chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever 103 degrees for 24-36 hours post immunization. Treatment Tylenol: recovered. 9 days post immunization rash (2-3 slightly red and raised areas) to face, arm, leg.
Patient is complaining of numbness on the left side of the face, light headness, weakness and his left arm starting to feel numb.
Fever chills hurt all over. Muscle and joint pain. Nausea, and gerneral awful feeling. Injection site pain. Are at site swollen.   And now have red streaks  3? long in swollen area.
mo noticed rash on extremities & then trunk while driving home from clinic; pt is playing not complaining; no SOB; will call PMD; MD said looked like react to vax;
This spontaneous report was received from a registered nurse, referring to unspecified patients. Patients' medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patients were vaccinated with improperly stored RECOMBIVAX HB, lot # L038018 and expiry date 13-SEP-2017 (strength, dose, anatomical location and route were not reported). No adverse events were reported and no product complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Moderna COVID-19 Vaccine EUA:  - Lump on the injection site (left arm) starting the day after and starting to fade away 4 days after the shot  - Lump next to the right nipple (lymph node - I assume) starting 4 days after the shot
Non-itchy scaly patch (~1/4 inch in diameter) above clitoris. Diagnosed as post-menopausal lichen sclerosis. Gradually sloughed-off over a two-week period of gentle scrubbing with water, followed by tearing of the vulva and white spots on labia. Doctor prescribed treatment of cortisone cream cleared up spots and healed tearing over several weeks.
Pt reported increasing fevers as well as associated body aches, joint pain, and chills like she had experienced when she actually had COVID-19 back in the fall. Most recent chemo was 4/8/21. Sent to ED
pt recv vax 12MAY97 & recv an inj in each anterior thigh;w/in 24hr pt devel low grade fever t99.8, urticarial rash gen & induration & tenderness to both thighs;lt greater then right;advised warm compresses to thighs, APAP, DPH given;
Swollen erythematous left thigh involved upper thigh to knee area. Symptoms began about 8 hours after injection and worsened over 24 hour period.
Blisters; Pain; Isolation; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of blister in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced blister (Verbatim: Blisters), pain (Verbatim: Pain) and patient isolation (Verbatim: Isolation). The outcome of the blister, pain and patient isolation were not recovered/not resolved.   It was unknown if the reporter considered the blister, pain and patient isolation to be related to Shingles vaccine.     It was unknown if the company considered the blister, pain and patient isolation to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 28-FEB-2023 This case was reported by the patient friend via interactive digital media. The reporter patient received two Shingle shots and was now dealing with blisters, pain and isolation. The reporter thought the shots would cover the situation. The follow up would not possible as no contact details were available.
Vomiting; This is a spontaneous report from a contactable consumer, the patient. An 88-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the right arm on 25Feb2021 at 10:00 (at the age of 88-years-old) as a single dose for COVID-19 immunisation. Medical history included congestive heart failure (CHF) and atrial fibrillation (AFIB). The patient had no known allergies. Concomitant medications included apixaban (ELIQUIS), atorvastatin calcium (LIPITOR), isosorbide mononitrate (IMDUR), metoprolol (MANUFACTURER UNKNOWN), furosemide (LASIX) and potassium (MANUFACTURER UNKNOWN); all taken for unknown indications from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced vomiting on 27Feb2021 at 13:30 and also on 28Feb2021 (at the time of this report) in the afternoon. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vomiting was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
He developed rash and fluid-filled blisters on one leg, which has then **extended to both arms**; He developed rash and fluid-filled blisters on one leg, which has then **extended to both arms**; This is a spontaneous report from a contactable consumer or other non hcp. A 58-year-old male patient received bnt162b2 (BNT162B2, solution for injection), dose 2 via an unspecified route of administration on 21May2021 as SINGLE DOSE, 2ND DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced he developed rash and fluid-filled blisters on one leg, which has then extended to both arms on an unspecified date, he developed rash and fluid-filled blisters on one leg, which has then extended to both arms on 22May2021. She explained since the following day, Saturday, he developed rash and fluid-filled blisters on one leg, which has then extended to both arms. She explained his symptoms are getting worst with time but is not severe. She described the blisters as: small, filled with liquid, some are appearing and disappearing and there are about ten of them. The action taken in response to the event for bnt162b2 was not applicable. The outcome of the event he developed rash and fluid-filled blisters on one leg, which has then extended to both arms was unknown and he developed rash and fluid-filled blisters on one leg, which has then extended to both arms with outcome of not recovered.  Follow-up attempts are needed. Additional information has been requested.
Diagnosed with rheumatoid arthritis 10/21, symptoms began in 07/22.
dizzy, generalized weakness, elevated HR, tongue numbness. Evaluated by EMS-Refusal to transport.
swelling on left arm from the elbow to the shoulder; Hot at injection site; itchy at injection site; red at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling on left arm from the elbow to the shoulder), VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE PRURITUS (itchy at injection site) and VACCINATION SITE ERYTHEMA (red at injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 15-Mar-2021, the patient experienced PERIPHERAL SWELLING (swelling on left arm from the elbow to the shoulder), VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE PRURITUS (itchy at injection site) and VACCINATION SITE ERYTHEMA (red at injection site). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at an unspecified dose and frequency. On 22-Mar-2021, VACCINATION SITE ERYTHEMA (red at injection site) was resolving. At the time of the report, PERIPHERAL SWELLING (swelling on left arm from the elbow to the shoulder), VACCINATION SITE WARMTH (Hot at injection site) and VACCINATION SITE PRURITUS (itchy at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Pt was admitted on 4/26 with gallstone pancreatitis and COVID pneumonia. She was found to be COVID positive in the ER prior to transfer.
Had a reaction to flu, hep A shot given on 11/16/02. Rash on both arms along with chest.
This spontaneous report as received from a nurse refers to a 1 year old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 07-SEP-2017, the patient was vaccinated with improperly stored VAQTA (dosing details were not reported) (lot # N017094, expiry date: 31-AUG-2018) for prophylaxis. No adverse effects were reported. Temperature excursion was from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA007011: US-009507513-1709USA007012: US-009507513-1709USA007013: US-009507513-1709USA007014: US-009507513-1709USA000054.
Given flu vaccine and covid vaccine on same day (not sure of which brand of flu vaccine I took). 3 days after booster (10/26/21), I broke out into hives. Originally, it was only a few hives, and I went to an urgent care and was given a prednisone triamcinolone acetonide (12 day taper). I completed using the cream after the 2 week period for the booster to hit full effectiveness. It stayed roughly the same, until around 01/01/2022, when I was covered in gigantic hives to the point that movement was painful. I did a telehealth visit with a dermatologist. I was given methylprednisolone with a 6 day taper. I was given the ointment version of that cream afterwards. Once I was done with this taper, the hives have been smaller and more manageable, but almost every day I still have some hives. My PCP is trying to get me into an appointment with a hive specialist for testing. I had chronic hives once before due to an allergy to tide laundry detergent, it was a 5 years period. But after that period, it was 5 or 6 years since that event with no hives in between then and the current breakout.
lt arm swelling & pain started 1wk p/inj;ice, APAP;
Patient had dry cough starting day of vaccine and lasting for 1 week with first dose and second dose.  Patient did not treat and it went away on its own.
Per records submitted by the hospital:  Symptoms began 7/16, went to urgent care 7/19 with fever and cough, treated with albuterol and doxycycline. Hospital ED 7/22 after vertigo and a fall, hypoxic, placed on bipap.  Diagnosed with CHF and pneumonia. Intubated 7/24/2021 and in ICU.  Client had CABG 5/23/2021 and had post op complications with a-fib, AKI, hypervolemia and had 3 thoracentesis. Submitter does not have access to full medical record.
Today one of the nurses use a Gray top COVID Vaccine to vaccinated a 10 year old, instead of using the orange top. The doses given of the gray top was 0.2 mL.
symtpms: swollen lymph nodes under right arm pit, and right side of  neck. Sever cold sore eruption covering all of  top and bottom lip after many years being cold sore free and never having full lip outbreaks or outbreaks on bottom lip. Ulcer/sores on right inside  portion of  upper and lower guns above and below the teeth. Small blisters on inside mucosa of nostrils. Tired with body aches, Mild cough, sneezing and runny nose.
This spontaneous report as received from a pharmacist refers to a 2 month old patient. On an unknown date in approximately 2013 (reported as within the past few days) the patient was vaccinated with a dose of GARDASIL (dose, route and lot number were not reported). No other concomitant medications were reported. It was reported that the patient was inadvertently administered GARDASIL instead of PEDVAXHIB at an outside clinic. No adverse effects were noted. Staff error only. The patient did not seek medical attention. Additional information has been requested.
4/15 at 4 am woke up after tossing all night from sore arm and had nausea. Heaved a couple times and took zofran to counter nausea. At 7 am developed fever 100.3 and diarrhea. Diarrhea continued til lunch time at which time i also experienced chills and sweating. Went home from work and tried to sleep it off while making several trips to the bathroom with diarrhea becoming increasingly watery. This continued with headaches, and  fever would continue as the excedrine or ibuprpfen wore off etc through all of friday with miscle aches so severe it was difficult to stand friday (unless i took ibuprofen). Saturday fever continued with mild headaches and immodium was started to treat watery diarrhea still present. Called an on call physician with allina health who assumes it's all part of the vaccine reaction and said i was probaby still ok to stay home and try to push fluids, though my appetite had slowed with immodium. Sunday immodium mostly staunched the flow of diarrhea and i ate almost normal amount of meals. Still had mild 99.0 temp before last dose of excedrine at 930 pm 4/18, excedrine was taken to squash the migraine i was experiencing for 4 hours on sunday evening. On 4/19 fever resolved, no bowel movements yet today, headache resolved but still have back ache from a now irritated gallbladder.
Post vax, the pt complained of general aching in all joints which started 3 days after vax was given.
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 12-APR-2016, the patient was vaccinated with an improperly stored dose of ROTATEQ (orally, dose was not reported, lot # L035508, expiration date 12-MAY-2017). There was no adverse effect reported. The administrated dose of vaccine experienced the temperature excursion of 47 degrees Fahrenheit for 144 hours. There was no data logger involved. There were no previous excursions reported. This is one of several reports received from the same source. Additional information has been requested.
The day after the vaccination and the following day (today, two days later) experiencing shortness of breath. Not bad, but definitely noticeable. Presume it is vaccine and am monitoring, not concerned, just hadn't seen that listed as a side effect for this vaccine and wanted to report it in case others are also experiencing.
Left Arm induration, reddness, chest tightness 11/21/07-records received for DOS 11/13-11/14/07-DC DX: Acute allergic reaction/atypical reaction to Pneumovax. Atypical chest pain, noncardiac, non-pulmonary emboli. Status post hysterectomy. Tubal ligation. History of carpal tunnel. Diabetes type 2. Hypertension, diet controlled at this time. On 11/12/07-received 2nd pneumonia vaccine accidentally. Had one previous in last 5 years. C/O sore swollen and erythematous arm, awoke next day with generalized myalgia and retrosternal discomfort with assoicated left arm discomfort.
vaccine was given 4 weeks early. first vaccine was given on April 6 and bivalent was administered on May 5
SUSPECTED IMMUNOLOGICAL VACCINE FAILURE; This spontaneous report received from a pharmacist concerned 3 patients.  The patient's weight, height, and medical history were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported, with frequency 1 total administered for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the pharmacist reported that 3 patients called in pharmacy to ask why their antibodies tests were found negatives after receiving the Janssen covid19 vaccine. The pharmacist stated that she had no other information on the patients to make the report at this time. Laboratory data (dates unspecified) included: antibody test (NR: not provided) negative (units unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of suspected immunological vaccine failure was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20210551549-covid-19 vaccine ad26.cov2.s -Suspected immunological vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
7/22/2021 headache, nausea, D, chills, 101.4 fever, 24hr fever, fatigue and tiredness for three days. Contacted nurse for appointment after 24hrs from start, 07/23/2021.
Given 0.5mL of Moderna as booster dose after receiving Johnson & Johnson initial dose in 2021.  Should have received 0.25mL of Moderna.  Attempted to notify patient via phone and mail.
Abnormal eye movements. Eyes migrate down, cross in middle, and then vibrate horizontally.
Headache; Sore arm; This case was reported by a consumer via interactive digital media and described the occurrence of headache in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of headache (patient received 1st dose on an unknown date and experienced headache and sore arm, refer case US2021AMR202845).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, 1 day after receiving Shingles vaccine, the patient experienced headache and pain in arm. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the headache and pain in arm were unknown.   It was unknown if the reporter considered the headache and pain in arm to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The patient just had a headache the day after getting the Shingles shot and a sore arm. The follow-up would not possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR202845:same reporter, same patient, same suspect, different dose (1st dose)
After a couple of days I developed a large redness in my left arm under the vaccination location.  It grew larger and was hot to the touch. On Wednesday, October 7th, I ended up going to my primary care physician, Dr. who prescribed a Zpac which took care of the adverse event.
head pressure, runny nose, congestion, mucus, no appetite, some diarrhea, feverish, chills, cough, headache. starting 10/30/21. Note: received Pfizer 3rd dose on 10/26/21. Lot numbers for vaccines not available/documented in his medical record
This spontaneous report was received from a Medical assistant regarding a 14 years old male patient of unknown gender. No pertinent medical history was reported. On 19-APR-2013 the patient was vaccinated with the first dose of GARDASIL (lot number reported as 1397AA expiration date 09-APR-2013) (0.5ml, intramuscular). No other suspect therapies or concomitant medications were reported. The Medical assistant reported that the patient received an expired dose of GARDASIL. No adverse effects reported. Additional information has been requested.
Patient became nauseous 7-8 minutes after receiving the vaccine. She was dry heaving. O2 sats were normal, HR was 100 but quickly came back down to lower 80s. She was monitored for an additional 30 minutes. There was no swelling at the injection site. The patient reported a slight headache but stated she felt much better after having water and crackers. She stated she felt ready to leave at the end of observation.
developed slight nausea while walking about 14 hours after second dose and that quickly turned into loss of hearing and vision after standing still for a few minutes. Blacked out for about a minute and lost consciousness but was able to still stand either because I was holding onto something or someone was helping me (not sure).  Came to and was drenched in sweat and stomach was churning. Hearing and vision came back after a few minutes. About an hour later, full body chills and body aches.
Admitted to hospital for osteomyelitis of toe. Discovered to have cellulitis of arm, at site of Pneumovax (from previous admission).  2/12/08 Reviewed hospital med records which reveal patient was hospitalized for pain & osteomyelitis of left 5th toe w/subsequent amputation 8/1-8/6/06.  While hospitalized, received pneumovax.  No vax record available.  Readmitted 8/8-8/9/06 for cellulitis of left foot near amputation site & also cellulitis of pneumo site left arm.  The vax site had erythema, warmth & pain.  Left foot cellulitis was actually contact dermatitis.  D/C to home on continued oral antibiotics. FINAL DX: left arm cellulitis at Pneumovax site.
The pt experienced urticaria within 24 hours post vax. The pt also had the same reaction with the 1st dose.
This case was reported by a consumer via call center representative and described the occurrence of myalgia in a 59-year-old female patient who received SHINGRIX. Concurrent medical conditions included pre-diabetes. Concomitant products included gabapentin, vitamin D, MOTRIN, Vitamin B12, Cinnamon, Cranberry Tablets, fish oil and TYLENOL. On 26th March 12:00, the patient received the 1st dose of SHINGRIX .5 ml. In March 2018, 13 hrs after receiving SHINGRIX, the patient experienced myalgia, fatigue, shivers, feeling unwell, cold, pain in arm and loss of energy. On an unknown date, the outcome of the myalgia, fatigue, shivers, feeling unwell, cold, pain in arm and loss of energy were recovering/resolving. The reporter considered the myalgia, fatigue, shivers, cold, pain in arm and loss of energy to be related to SHINGRIX. The reporter considered the feeling unwell to be unlikely related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX vaccine around 12:00 noon on 26th March, 2018 and she claims that during the night around 1:00 AM she woke up not feeling well and she felt sick with symptoms and did not feel quite right. She explained that she felt sick with symptoms and did not feel quite right. She explained that she experienced myalgia, an achy feeling, and she had to take a nap which she usually did not need to do. The patient took a TYLENOL and started to feel better. The patient had taken a MORTIN or TYLENOL three times since the vaccination and she would feel better until the medication wears off. The patient denied permission to contact their physician.
pt recvd vax; swelling, redness & "streaking: on lt arm w/ 24 hrs of vax; had both TT & IPV in lt arm;